ALECENSA vs VONJO

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated June 7, 2026·How we rate

Possible drug interaction. ALECENSA and VONJO are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	ALECENSA	VONJO
Rating	New	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	ALECTINIB HYDROCHLORIDE	PACRITINIB CITRATE
Manufacturer	Hoffmann La Roche	Sobi
Dosage forms	Capsule	Capsule
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	None
Treats	Non-Small-Cell Lung Carcinoma	Primary Myelofibrosis

alecensa vonjo

Rating

New

Pharmacy pays

—

Type

Active ingredient

ALECTINIB HYDROCHLORIDE

PACRITINIB CITRATE

Manufacturer

Hoffmann La Roche

Sobi

Dosage forms

Capsule

Drug class

Kinase Inhibitor

Boxed warning

None

Treats

Non-Small-Cell Lung Carcinoma

Primary Myelofibrosis

Frequently asked questions

What is the difference between Alecensa and Vonjo?

Alecensa contains Alectinib Hydrochloride, while Vonjo contains Pacritinib Citrate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.